Italian prosecutors issue arrest warrant for Signa’s René Benko
Nine people under house arrest or being sought for suspected malfeasance linked to property sector
Italian prosecutors have issued a warrant for the arrest of Austrian property tycoon René Benko amid an investigation into alleged improprieties with his business in the sud-Tyrol region, two law enforcement officials familiar with the matter confirmed.
In total, nine people — including the mayor of a small Italian town, a city manager, three business people and four professionals — have been put under house arrest or are being sought for suspected malfeasance linked to the property sector in the Trentino-Alto Adige region, the Trento prosecutor’s office said on Tuesday.
The arrest warrants mark the latest twist in the insolvency of Benko’s Signa conglomerate, which saddled banks, insurance companies and other investors in Austria and Germany with billions of euros in losses.
Creditors have accused a key entity in the Signa group of engaging in “unlawful transactions” before it filed for insolvency last December. Austria’s anti-corruption prosecutors in April opened an investigation into fraud allegations.
Prosecutors on Tuesday said investigations by Italy’s anti-mafia unit had revealed the apparent existence of “a business group capable of influencing and/or controlling” major public initiatives, “especially in the sector of building speculation” in Trentino-Alto Adige.
“The entrepreneurs involved would make themselves available to finance the electoral campaigns of public administrators, obtaining benefits, simplified procedures and concessions for real estate initiatives,” the prosecutors’ statement said.
Norbert Wess, a lawyer for Benko, said in an emailed statement that no European arrest warrant would be executed against his client. He also said Austrian authorities “had not imposed any other conditions or obligations on Mr Benko”.
Austria’s postwar constitution forbids the extradition of its citizens to participate in foreign court proceedings.
“Mr Benko will continue — as before — to co-operate fully with all national and international authorities and is confident that any allegations against him can be clarified as substantively incorrect.”
Benko was one of Europe’s most flamboyant property developers, whose empire acquired stakes in New York’s Chrysler Building, London’s Selfridges and even the building that houses Austria’s constitutional court in Vienna.
But his flagship holding company, Signa, disintegrated last year under pressure from its billions of euros of debt, and Benko filed for personal insolvency earlier this year.
Signa projects in the Alto-Adige region included an ambitious mixed-use shopping centre, office and apartment complex in the heart of Bolzano, just a short distance from the town’s historic cathedral.
Benko made the area his second home, buying several luxurious properties around Lake Garda for the use of him and his family through his Liechtenstein-based personal foundation.
In addition to issuing the warrants on Tuesday, authorities also searched more than 100 locations in Trento, Bolzano, Milan, Rome, Brescia and other Italian cities.
In total, the prosecutor’s statement said 77 people were under investigation in the case, including 11 public officials and 20 managers of local public offices and public sector companies, as well as some law enforcement officials and local businesspeople.
Among the charges being levied against those suspected of involvement in the matter include criminal conspiracy, fraud, bid-rigging, illicit financing of political parties, undue receipt of payments to the detriment of the state, corruption and revelation of official secrets, the prosecutors statement said.
South Korea’s President Declares Martial Law Citing Threat of Pro-North Korean Forces
Members of Yoon Suk Yeol’s own ruling party say they will try to block the move that halts certain political activities
SEOUL—South Korea’s president declared martial law, telling his country in a televised address Tuesday night that opposition parties had made the country vulnerable to North Korean “communist forces.”
Yoon Suk Yeol, a conservative who took office in 2022, accused the opposition party, which controls the country’s National Assembly, of holding the country hostage. He cited the rejection of a budget proposal and impeachment cases against South Korea’s top prosecutors as threats to the country’s constitutional order.
“The martial law is aimed at eradicating pro-North Korean forces and to protect the constitutional order of freedom,” the 63-year-old Yoon said.
Members of Yoon’s own ruling conservative People Power Party said they would seek to block the move—the first declaration of martial law since 1980 when South Korea was under military rule. The opposition Democratic Party, which can request a lifting of martial law, called for an emergency meeting at the National Assembly late Tuesday after Yoon’s address.
The martial law command proclaimed that any political activities by South Korea’s unicameral, 300-seat parliament are banned, as well as nationwide curtailment of rallies and protests. It also calls on all medical personnel to return to work within 48 hours, among other measures.
By law, the National Assembly can lift martial law through a majority vote and requires the president to comply. The opposition Democratic Party enjoys majority control with 170 seats.
But access to the National Assembly building, where a vote could take place, appeared to be limited with the entrance guarded by police, according to local news footage.
Research Calls I
-
Upgrades:
- Alignment Healthcare (ALHC) upgraded to Overweight from Equal-Weight at Stephens; tgt raised to $17
- AngloGold Ashanti (AU) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt $31
- Ashtead (ASHTF) upgraded to Outperform from Sector Perform at RBC Capital Mkts
- Axon (AXON) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $700
- BMW Group (BMWYY/BMWKY) upgraded to Buy from Neutral at UBS
- CenterPoint (CNP) upgraded to Buy from Neutral at UBS; tgt raised to $37
- Century Aluminum (CENX) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $27
- Citigroup (C) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $82
- Credo Technology Group (CRDO) upgraded to Buy from Underperform at BofA Securities; tgt $80
- CVS Health (CVS) upgraded to Buy from Hold at Deutsche Bank; tgt $66
- Dana Inc (DAN) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt raised to $16
- DTE Energy (DTE) upgraded to Buy from Neutral at UBS; tgt raised to $143
- Hugo Boss AG (BOSSY) upgraded to Buy from Neutral at UBS
- Kroger (KR) upgraded to Buy from Hold at Jefferies; tgt raised to $73
- PTC Therapeutics (PTCT) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $63
- South Atlantic Bancshares (SABK) upgraded to Buy from Neutral at Janney; tgt $19
- State Street (STT) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $120
- Synchrony Financial (SYF) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $85
- Upstart (UPST) upgraded to Buy from Neutral at Redburn Atlantic; tgt raised to $95
-
Downgrades:
- Cavco Industries (CVCO) downgraded to Neutral from Outperform at Wedbush; tgt $480
- Cousins Prop (CUZ) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt raised to $32
- EssilorLuxottica (ESLOY) downgraded to Neutral from Buy at UBS
- FedEx (FDX) downgraded to Mkt Perform from Outperform at Bernstein; tgt lowered to $316
- Kroger (KR) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt $60
- Ollie's Bargain Outlet (OLLI) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $95
-
Others:
- AGCO Corp (AGCO) initiated with an Equal-Weight at Morgan Stanley; tgt $101
- ASM Intl NV (ASMIY) initiated with a Neutral at Exane BNP Paribas; tgt $561
- ASML (ASML) resumed with an Outperform at Exane BNP Paribas; tgt $858
- Coca-Cola European Partners (CCEP) initiated with a Mkt Perform at Bernstein; tgt $82
- Coca-Cola Hellenic (CCHGY) initiated with an Outperform at Bernstein
- EQT Corp. (EQT) resumed with a Sector Perform at RBC Capital Mkts; tgt $49
- Eversource Energy (ES) initiated with an Underperform at Jefferies; tgt $52
- Everus (ECG) initiated with a Peer Perform at Wolfe Research
- FedEx (FDX) added to Positive Catalyst Watch ahead of earnings at JP Morgan
- Instacart (CART) initiated with a Hold at Deutsche Bank; tgt $37
- Integer Holdings (ITGR) resumed with an Overweight at Wells Fargo; tgt $160
- iRhythm (IRTC) resumed with an Equal Weight at Wells Fargo; tgt $86
- Lamb Weston (LW) initiated with a Mkt Perform at Bernstein; tgt $85
- Nevro (NVRO) initiated with an Equal Weight at Wells Fargo; tgt $5
- STMicroelectronics (STM) initiated with a Neutral at Exane BNP Paribas; tgt $28
Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CLSK -8% (to delay 10-K filing), ZS -6.9%, TMDX -6.3% (narrows guidance; names new CFO), MCHP -1.4%, HON -1.4% (guidance; strategic agreement with Bombardier), BNS -1.4%, CR -0.5% (selling Engineered Materials business; revises guidance)
Other news:
- INDI -15.5% ($175 mln convertible notes offering)
- X -7.2% (President-elect Trump repeats that he will seek to block Nippon Steel's bid for US Steel)
- ELTX -5% (Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment)
- AS -4.3% (stock offering)
- RCAT -3.9% (leadership changes)
- BILL -3.5% ($1.0 bln convertible senior notes)
- MARA -3.4% (prices offering of $850 million of 0.00% convertible senior notes due 2031)
- RVMD -3% ($600 mln stock offering)
- ROIV -2.5% (Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab)
- RM -2.1% ($30 mln repurchase plan and 2025 growth expectations)
- CNTX -1.9% ($75 mln common stock offering)
- FLR -1.6% (CFO to retire; names new CFO)
- MESO -1.5% (reports Revascor improves survival and reduces major morbidity in high-risk Ischemic Heart Failure patients with inflammation)
- SAIA -1.4% (Q4 operating data)
- IPAR -1.2% (to develop off-white brand in fragrance)
Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CRDO +32.8%, CNM +8.5%, T +3.3% (guidance), SJM +1.3% (closing of transaction to divest Voortman business; updates FY25 revenue guidance), DCI +1.1%, ENB +0.8% (guidance), AMAT +0.5% (guidance)
Other news:
- JANX +73% (doses selected for Phase 1b trials)
- CHRS +32.8% (enters into asset purchase agreement with Intas Pharmaceuticals for the divestiture of the UDENYCA franchise for up to $558.4 mln)
- CRBP +5.9% (grants fast track designation to CRB-701 for the treatment of relapsed or refractory metastatic cervical cancer)
- TERN +5.9% (Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia)
- SPIR +4.7% (appoints Theresa Condor as CEO and taps aerospace industry veterans for executive team)
- INGM +4.3% (restructuring and reducing headcount)
- RYN +4.1% (special dividend)
- JSPR +3.8% (first patient dosed in ETESIAN Clinical Study)
- RYTM +3.2% (announces Imcivree receives expanded marketing authorization in the United Kingdom for treatment of obesity and control of hunger in patients)
- IONQ +3.1% (unveils quantum OS)
- KELYA +3% (approves share repurchase program authorizing purchase up to $50 million of its Class A common stock)
- COMP +2.8% (partnering with multiple entities)
- IMCR +2.5% (announces reimbursement agreement in England for KIMMTRAK)
- PVBC +2.4% (adopts 5% repurchase plan)
- JOBY +2.3% (CFO to resign)
- RNAC +2.2% (updated results in participants with myasthenia gravis and outlines design of planned Phase 3 Trial)
- BWMN +1.7% (increases repurchase plan)
- TELO +1.4% (announced compelling preclinical results demonstrating the ability of its licensed molecule, Telomir-1, to reverse insulin resistance to near pre-diabetes levels in a zebrafish model of Type 2 diabetes mellitus)
- VEON +1.3% (In an Open Letter to VEON Investors, VEON Group CEO Welcomes the Unfreezing of VEON's Corporate Rights on Kyivstar)
- HAE +1.2% (enters sale of whole blood assets to GVS, S.p.A)
- MIR +1.2% (to detail financial targets and long-term strategy at today's investor day; will also announce a share repurchase program for up to $100 million of the currently outstanding shares of the company's Class A common stock)
- PCG +1.1% (prices common stock and mandatory convertible Preferred Stock offerings)
- PTLO +1% (appoints new COO)
- WPP +1% (completed the transaction to sell its majority stake in FGS Global to Kite Bidco)
Trump Tariffs on China Will Cause Pain Elsewhere. Stocks to Play It.
All’s fair in love and a global trade war.
Donald Trump looks set to reignite his tariff war with China when he returns to the White House. But a different and friendlier region will become collateral damage.
Europe may well be faced with its own Trump tariffs but it’s those aimed at Beijing that could be more detrimental for the region. That’s because Europe’s economy depends more on international markets than domestic, and needs seamless global trade–something that would be impacted by levies.
However, some specific stocks and sectors can still do well even if the European economy overall suffers, particularly as the region’s shares are undervalued and due for some amount of catch-up with their U.S. peers. Consumer staples, utilities, and technology are sectors that may be worth a look.
Even before the prospect of tariffs, the outlook for Europe was already darkening – UBS just downgraded its prediction for the Euro STOXX 50 next year. That index has gained about 7% this year, compared with a 19% increase for the Dow Jones Industrial Average. The continent is still coping with higher energy costs than in the U.S., particularly since Russia invaded Ukraine in 2022, as well as its exposure to the slump in China, another of its major trading partners.
On the campaign trail, Trump said he favored across-the-board tariffs, and on Nov. 25, he promised a 25% tariff on imports from Mexico and Canada, along with an additional 10% tariff on goods from China.
Even if he hasn’t spelled it out yet, European companies will probably also have to cope with Trump’s tariffs on exports to the U.S.–things like luxury handbags produced by LVMH’s Louis Vuitton brand, Ferrari cars made in Italy, or Talisker Scotch whiskey shipped by Diageo. About 20% of exports from the European Union and the U.K. go to the U.S.
But levies on European products may not be that damaging overall, according to strategists at UBS. For one thing, most of what Europe exports are services, not goods, which wouldn’t be affected. Second, a lot of what we might think of as European exports, such as Volkswagen or Bayerische Motoren Werke
BMW
+1.39%
cars, are actually made in the U.S. already, which would also make them exempt from the new levies. And third, Trump’s tariffs would probably drive up the dollar against other currencies, which would lessen the impact of the costs on the revenues of European companies.
The greater threat to Europe is how the tariffs affect Asia and the rest of the world.
“My bigger concern is the knock-on effect on global growth and the impact to end demand,” said Matthew Gilman, a European equity strategist at UBS. “Tariffs can disrupt supply chains, they increase trade frictions, and we are very exposed to what’s going on in global manufacturing.”
Other countries will almost certainly retaliate by adding tariffs of their own. China may also respond by ramping up exports elsewhere. Europe would be in its sights–a flood of Chinese imports, as the continent has already seen with electric vehicles, would increase competition and push down prices.
“Certainly Europe is more sensitive to what’s going on in China,” said Martin Todd, a fund manager at investment manager Federated Hermes. “It’s easy to make quite a bearish case for Europe. The obvious push back to that is valuations for European stocks.”
Todd points out that there are bright spots–European stocks currently trade at about 14 times forward earnings, which is at the low end of their historic range, Todd said. U.S. stocks, by contrast, are trading at more than 22 times earnings, which, compared with an average of 20 over the past five years, is “well above historic levels.”
The outlook isn’t all bad for stocks. If the theme of a new Trump administration becomes self-reliance, then UBS sees several sectors that stand to gain in Europe–consumer staples, utilities, and technology.
For consumer staples, the argument is that even though spirits like Scotch would be affected by tariffs, sales of many goods would be unaffected. For example, European consumers will still have to buy household goods from companies like Unilever, which owns Dove soap and more than 30 other brands. Or there’s Switzerland-based Nestle, which owns Gerber baby foods. The iShares MSCI Europe Consumer Staples ETF (ticker ESIS) is already beaten down, having dropped about 5% since the start of the year, compared with a 5.8% gain for the STOXX Europe 600 index.
Utilities may do well as companies and countries are forced to invest more in the energy transition away from fossil fuels. Examples include France’s EDF or Germany’s E.ON. The risk for this sector is an end to the Russia-Ukaine war that lowers natural gas prices again, which might hurt these stocks.
Europe’s technology companies haven’t had the same spectacular growth as U.S. peers recently, but that could make them interesting. SAP, the German business software company, or semiconductor maker Infineon offer potentially high growth rates, but largely fly under the radar because they don’t have their main listing in the U.S.
Defense companies in Europe could benefit if Trump follows through on threats to reduce military support to allies. Other countries may increase their defense spending as a result and France’s Thales, Germany’s ThyssenKrupp, and the U.K.’s BAE Systems are companies that stand to gain–and all have underperformed the S&P 500 this year.
But with new tariffs in the pipeline that will twist the knife of Europe’s vulnerability to Chinese economic weakness, companies across the pond are bracing for turbulence.